Home>>Signaling Pathways>> Metabolism>> phosphatases>>Calyculin A

Calyculin A

(Synonyms: 蛋白磷酸酯酶抑制剂,(-)-Calyculin A) 目录号 : GC18106

Calyculin A是蛋白磷酸酶1(PP1)和蛋白磷酸酶2A(PP2A)的强效抑制剂, IC50值分别为2nM和0.5–1.0nM。

Calyculin A Chemical Structure

Cas No.:101932-71-2

规格 价格 库存
10μg
¥1,932.00
待询
50μg
¥3,850.00
待询

电话:400-920-5774 Email: sales@glpbio.cn

Customer Reviews

Based on customer reviews.

Sample solution is provided at 25 µL, 10mM.

102

客户使用产品发表文献 1

Description

Calyculin A is a potent inhibitors of protein phosphatases 1 (PP1) and phosphatases 2A (PP2A), with IC50 values of 2nM and 0.5–1.0nM, respectively[1]. Calyculin A is a major cytotoxic compound isolated from the Japanese marine sponge Discodermia calyx[2]. Ascribed to the specific and potent inhibition of PP1 and PP2A, Calyculin A is widely used for evaluating intracellular signal transduction[3] and cancer research[4].

Calyculin A (10nM; 6h) treatment can induce inhibition of PP1 and PP2A activities and changes in immunoreactivity of PP1c and PP2Ac in MCF7 cells[5]. Calyculin A (1nM; 1h) stimulated TNF-α transcriptional activity and increased the expression of TNF-α in MC3T3-E1 cells[6].

Calyculin A (0.8μg/kg) significantly enhanced the positive inotropy and improved the diastolic function of left ventricle by increasing stroke work, cardiac output, stroke volume, ejection fraction, the slope of the left ventricular end-systolic P-V relationship (Ees) and by decreasing the slope of the left ventricular end- diastolic P-V relationship (Eed) in rats[7].

References:
[1]. Ishihara H, Martin BL, Brautigan DL, et al. Calyculin A and okadaic acid: inhibitors of protein phosphatase activity. Biochem Biophys Res Commun. 1989 Mar 31;159(3):871-7. doi: 10.1016/0006-291x(89)92189-x. PMID: 2539153.
[2]. Wakimoto T, Egami Y, Abe I. Calyculin: Nature's way of making the sponge-derived cytotoxin. Nat Prod Rep. 2016 Jun 2;33(6):751-60. doi: 10.1039/c5np00123d. PMID: 26923942.
[3]. Antaraki A, Ang KL, Antoni FA. Involvement of calyculin A inhibitable protein phosphatases in the cyclic AMP signal transduction pathway of mouse corticotroph tumour (AtT20) cells. Br J Pharmacol. 1997 Jul;121(5):991-9. doi: 10.1038/sj.bjp.0701228. PMID: 9222558; PMCID: PMC1564779.
[4]. Edelson JR, Brautigan DL. The Discodermia calyx toxin calyculin a enhances cyclin D1 phosphorylation and degradation, and arrests cell cycle progression in human breast cancer cells. Toxins (Basel). 2011 Jan;3(1):105-19. doi: 10.3390/toxins3010105. Epub 2011 Jan 24. PMID: 22069692; PMCID: PMC3210456.
[5]. Favre B, Turowski P, Hemmings BA. Differential inhibition and posttranslational modification of protein phosphatase 1 and 2A in MCF7 cells treated with calyculin-A, okadaic acid, and tautomycin. J Biol Chem. 1997 May 23;272(21):13856-63. doi: 10.1074/jbc.272.21.13856. PMID: 9153244.
[6]. Qiu L, Yoshida K, Amorim BR, et al. Calyculin A stimulates the expression of TNF-alpha mRNA via phosphorylation of Akt in mouse osteoblastic MC3T3-E1 cells. Mol Cell Endocrinol. 2007 Jun 15;271(1-2):38-44. doi: 10.1016/j.mce.2007.03.005. Epub 2007 Apr 4. PMID: 17482757.
[7]. HUANG Hui-li, XIE Ming, GAO Li, et al. Studies on hemodynamic effects of Calyculin A of protein phosphatase 1 and 2A inhibitor and its underlying mechanism in rats. Chinese Pharmacological Bulletin, 2018, 34(12): 1697-1702.

Calyculin A是蛋白磷酸酶1(PP1)和蛋白磷酸酶2A(PP2A)的强效抑制剂, IC50值分别为2nM和0.5–1.0nM[1]。Calyculin A是从日本海绵Discodermia calyx中分离出的主要细胞毒性化合物[2]。由于对蛋白磷酸酶1和蛋白磷酸酶2A的特异性和强效抑制,Calyculin A被广泛用于评估细胞内信号转导[3]和癌症研究[4]

Calyculin A (10nM;6小时)处理可以抑制PP1和PP2A活性,并改变MCF7细胞中PP1c和PP2Ac的免疫反应性[5]。Calyculin A (1nM;1小时)可以刺激TNF-α转录活性并增加MC3T3-E1细胞中TNF-α的表达[6]

Calyculin A (0.8μg/kg)处理显著增强了正性肌力作用,并通过增加搏功、心输出量、搏出量、射血分数、左心室收缩末期压力-容积关系曲线的斜率(Ees)和降低左心室舒张末期压力-容积关系曲线的斜率(Eed)来改善大鼠左心室的舒张功能[7]

实验参考方法

Cell experiment [1]:

Cell lines

MCF7 cells

Preparation Method

MCF7 cells were treated with 10nM Calyculin A for 6h. Then the soluble fraction of cell extracts was collected and used to measure protein phosphatases 1 (PP1) and 2A (PP2A) activity.

Reaction Conditions

10nM; 6h

Applications

Calyculin A inhibits the activities of PP1 and PP2A in MCF7 cells.
Animal experiment [2]:

Animal models

Sprague-Dawley Rat

Preparation Method

Rats were anesthetized then isolate the right common carotid artery and the left jugular vein. Insert a calibrated Millar pressure-volume catheter into the left ventricle via the right common carotid artery. Calyculin A was injected through the left jugular vein while recording the left ventricular pressure-volume loop (P-V loop), aortic pressure, and vascular hemodynamic parameters.

Dosage form

0.8μg/kg; i.v.

Applications

Calyculin A administered intravenously significantly enhanced the positive inotropy and improved the diastolic function of left ventricle.

References:
[1]. Favre B, Turowski P, Hemmings BA. Differential inhibition and posttranslational modification of protein phosphatase 1 and 2A in MCF7 cells treated with calyculin-A, okadaic acid, and tautomycin. J Biol Chem. 1997 May 23;272(21):13856-63. doi: 10.1074/jbc.272.21.13856. PMID: 9153244.
[2]. HUANG Hui-li, XIE Ming, GAO Li, ZHANG Wen-hui, CHEN Ke-su, LIU Fu-ming, CHEN Long. Studies on hemodynamic effects of Calyculin A of protein phosphatase 1 and 2A inhibitor and its underlying mechanism in rats. Chinese Pharmacological Bulletin, 2018, 34(12): 1697-1702.

化学性质

Cas No. 101932-71-2 SDF
别名 蛋白磷酸酯酶抑制剂,(-)-Calyculin A
化学名 N-[(3S)-[4-(1E)-3-[(2R,3R,4R,7S,8S,9R)-2-[(1S,3S,4S,5R,7E,9E,11E,13Z)-14-Cyano-3,5-dihydroxy-1-methoxy-4,6,8,9,13-pentamethyl-7,9,11,13-tetradecatetraenyl]-9-hydroxy-4,4,8-trimethyl-3-(phosphonooxy)-1,6-dioxaspiro[4.5]dec-7-yl]-1-propenyl]-2-oxazoly]butyl
Canonical SMILES CC1C(CC2(C(C(C(O2)C(CC(C(C)C(C(C)C=C(C)C(=CC=CC(=CC#N)C)C)O)O)OC)OP(=O)(O)O)(C)C)OC1CC=CC3=COC(=N3)C(C)CCNC(=O)C(C(C(COC)N(C)C)O)O)O
分子式 C50H81N4O15P 分子量 1009.18
溶解度 DMSO: Soluble,Ethanol: Soluble 储存条件 Store at -20°C, protect from light
General tips 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。
为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。
Shipping Condition 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。

溶解性数据

制备储备液
1 mg 5 mg 10 mg
1 mM 0.9909 mL 4.9545 mL 9.909 mL
5 mM 0.1982 mL 0.9909 mL 1.9818 mL
10 mM 0.0991 mL 0.4955 mL 0.9909 mL
  • 摩尔浓度计算器

  • 稀释计算器

  • 分子量计算器

质量
=
浓度
x
体积
x
分子量
 
 
 
*在配置溶液时,请务必参考产品标签上、MSDS / COA(可在Glpbio的产品页面获得)批次特异的分子量使用本工具。

计算

动物体内配方计算器 (澄清溶液)

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
给药剂量 mg/kg 动物平均体重 g 每只动物给药体积 ul 动物数量
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方)
% DMSO % % Tween 80 % saline
计算重置

产品文档

Quality Control & SDS

View current batch: